Showing results (21-30 of 86) with videos related to
Sort By:
Pageof 9
Frontiers in Pharmacology|January 9, 2019
The South African Regulatory System: Past, Present, and FutureAndrea Keyter, Shabir Banoo, Sam Salek, et al.Pharmacoepidemiology and Drug Safety|June 7, 2013
Is there a need for a universal benefit-risk assessment framework for medicines? Regulatory and industry perspectivesJames Leong, Neil McAuslane, Stuart Walker, et al.Therapeutic Innovation & Regulatory Science|June 1, 2018
The Regulatory Review Process in South Africa: Challenges and Opportunities for a New Improved SystemAndrea Keyter, Joey Gouws, Sam Salek, et al.Frontiers in Medicine|May 13, 2022
Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way ForwardTariro Sithole, Gugu Mahlangu, Stuart Walker, et al.Frontiers in Medicine|May 13, 2022
Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way ForwardTariro Sithole, Gugu Mahlangu, Stuart Walker, et al.International Journal of Health Policy and Management|December 10, 2020
A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective AgencyAndrea Keyter, Sam Salek, Shabir Banoo, et al.Frontiers in Pharmacology|February 8, 2019
The Reliability and Relevance of a Quality of Decision Making Instrument, Quality of Decision-Making Orientation Scheme (QoDoS), for Use During the Lifecycle of MedicinesMagdalena Bujar, Neil McAuslane, Stuart Walker, et al.International Journal of Health Policy and Management|July 3, 2020
A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of MedicinesMagdalena Bujar, Neil McAuslane, Stuart Walker, et al.Frontiers in Pharmacology|December 25, 2014
Strategy for communicating benefit-risk decisions: a comparison of regulatory agencies' publicly available documentsJames Leong Wai Yeen, Sam Salek, Stuart WalkerPharmaceutical Medicine|February 3, 2016
The Saudi Arabia Food and Drug Authority: An Evaluation of the Registration Process and Good Review Practices in Saudi Arabia in Comparison with Australia, Canada and SingaporeHajed Hashan, Ibrahim Aljuffali, Prisha Patel, et al.Pageof 9